Diagnostic Approach to Patients with Atypical Squamous Cells of Undetermined Significance Cytologic Findings on Cervix

Mahira Jahic, Elmir Jahic, Mahira Jahic, Elmir Jahic

Abstract

Background: Atypical squamous cells of undetermined significance (ASCUS) is a term that refers to inflammatory, reactive and reparative processes which are atypical and of higher level and insufficient to be classified as cervical intraepithelial lesions (CIN).

Aims: Examine of frequency of HPV infection in ASCUS lesions and regression, stagnation and progression during six-month period.

Subjects and methods: Prospective study was conducted over a period of 3 years. In private gynecological ambulance "Dr Mahira Jahic". Analysis of PAP smears and HPV typization have been done in 50 patients and PAP test has been repeated after six months. X² test was used for statistical analysis.

Results: Analysis of 1784 PAP smears showed normal results in 86,6% (N-1530), and abnormal in 13% (N-254). ASCUS in 7,4% (N-133) and ASC-H in 0,5% (N-9), LSIL in 4,4% (N-80), HSIL in 1,3% (N-24), CIN II in 1,2% (N-20), CIN III in 0,2% (N-4). Progression occurred in 18% (9), persistence in 74% (37) and regression in 8%. Patients with ASC-H lesion 0,5% (N-9), PH results showed 22% (N-2) Carcinoma in situ, 33% (N-3) CIN II, 22% (N-2) CIN I and 22% (N-2) chronic cervicitis. Patients with CIN I in 88% (N-7) were positive on HPV of high risk. Patients with persistent ASCUS result were positive in 51% (N-19). The number of CIN I lesions found in women with ASCUS is bigger and statistically significant (p<0,05) in relation to number of CIN I findings found in regular examinations.

Conclusion: Monitoring women with ASCUS lesion, especially HPV positive to high risk group is the best way of selection of women who should be treated and monitored in order to prevent cervical cancer.

Keywords: ASCUS; Cervical cancer prevention; HPV; Pap test.

Conflict of interest statement

• Conflict of interest: none declared.

References

    1. Filipi K, Xhani A. Assestment of cervical cytological data in Albanian females. Asian Pac J. Cancer Prev. 2014;15:2129–32.
    1. Solomon D, Nayar R The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. Vol. 4. New York: Springer; 2004. pp. 67–87.
    1. Nayar R, Wilbur D. The Pap Test and Bethesda 2014. Acta Cytologica. 2015;59:121–32.
    1. Barcelos A, Adad S, Michelim M, Murta E. Atypical squamous cells of undetermited significance: analisysis of microbiology, cytological criteria and clinical conduct. Tumori. 2006:213–8.
    1. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atipical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11:390–6.
    1. Gudice A, Rizzo M, Rossi RT, Bonaffini O, Buda CA, Petineo G. Diagnosis and survey of abnormal/atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesions: a retrospective study. Anticancer Res. 2000;20:195–9.
    1. Melnikoew J, Nuovo J, Willan AR. Natural hystory of cervical squamous intraepithelial lesions: meta-analisis. Obstet Gynecol. 1998;92:727–35.
    1. Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maieang K. Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASCUS) Papanicolaou smears. Asian Pac J Cancer Prev. 2011;12:235–8.
    1. Roche D, Spicer N. The clinical significance of atypical squamous cells of undetermined significance: a laboratory audit of cervical reporting. N Z Med J. 2001;114:64–6.
    1. Jahić M, Mulavdić M, Dautbašić F, Fejzić M, Jahić E. Frequency of precancerous changes and cervical cancer recorded in three health centres in tuzla canton in period 2010-2011. Materia Sociomed. 2013;25(4):259–61.
    1. Darragh T, Colgan T, Cox J. The Lower Anogenital Squamous Terminology Standardisation Project for HPV-Associated Lesions: background and consensus recomendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genital Tract Dis. 2012;16:205–42.
    1. Migel NL, Lachowicz CM, Kline TS. Candida -related changes and ASCUS: a potential trap! Diagn Cytopathol. 1996;16:153–7.
    1. Boardman LA, Stanko C, Weitzen S, Sung CJ. Atipical squamous cells of undetermined significance: human papilloma testing in adolescents. Obstet Gynecol Surv. 2005;60:435–7.
    1. Tokmak A, Guzel I, Ozgu E, Oz M, Akbay S, Erkaya S, Gungor T. Clinical Significance in Detecting Preinvasive Cevical Lesions in Post Menopausal Turkish Women. Asian Pacific Journal of Cancer Prevention. 2014;15:6639–41.
    1. Pirog EC, Erol M, Harigopal M, Centero BA. Comparison of human papilloma virus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the orginal Bethesda 1991 and the new Bethesda 2001 systems. Arch Pathol Lab Med. 2004;128:527–32.
    1. JahićM MulavdićM, HadžimehmedvićA JahićE. Association between aerobic vaginitis, bacterial vaginosis and squamous intraepithelial lesion of low grade. Med Arh. 2013;67(2):94–6.
    1. Wiliams ML, Rimi DL, Pedigo MA. Atipical squamous cells of undetermined significance: correlative histologic and follow up studies from academic medical centar. Diagn Cytopathol. 1997;161:1–7.
    1. Rinku S, Vijayalakshmi B, Anupama J, Poonam C. A prospective study of 86 cases of ASCUS (atipical squamous cells undetermined significance) over two year. J Opstet Gynecol India. 2007;57:73–6.
    1. Persson M, Elfstrom KM, Olsson SE, Dillner J, Andersson S. Minor cytological abnormalities and up to 7-year risk for subsequent high-grade lesions by HPV type. PLOS ONE. 2015 DOI 10/6 e0127444. doi: 10.1371/journal.pone.0127444.
    1. Castle PE, Sider M, Jeronimo J, Solomon D, Schiffman M. Risk assestment to guide the prevention of cervical cancer. Am J Obstet Gynecol. 2007;197:351–6.
    1. Katki HA, Sciffman M, Castle PE, Fetterman B, Poitraes NE, Lorey T. Benchmarking CIN 3 +risk as the basis for incorporating HPV and Pap cotesting into cervical screening and managment gudelines. Jlow Genit Tract Dis. 2013;17:28–35.
    1. Knocken M, Berkhof J, Van Kemenade FJ, Louwers JA, Zaal A, Nobbenhuis MA. Long-term CIN 3+risk in women with abnormal cytology;role of HPV testing. Br J Cancer. 2012;106:817–25.
    1. Stolen MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL. High risk human papilloma virus testing in women with ASCUS cytology: results from the ATHENA HPV tudy. Am J Clin Path. 2011;135:468–465.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir